DnaNudge founder co-chairs Royal Society report on neural interfaces

10th September 2019

Our CEO Professor Chris Toumazou is co-chair of a major new report published today by The Royal Society, "iHuman perspective: Neural interfaces", outlining how neural interfaces could transform medicine and treatment options in the near future.

Professor Toumazou's work is setting a completely new paradigm for minimally invasive and non-invasive consumer technology to tackle chronic disease - from early detection through to therapy. Professor Toumazou's research has long been focused on developing technology solutions to tackle major global health challenges.  His innovations in the area of obesity treatment and prevention include intelligent AI-based vagus nerve stimulation to replace stomach bypass operations (the recipient of a €7 million European Research Council grant) and, now, DnaNudge, which launches its first retail store in the UK next month. DnaNudge is the world's first DNA-based service to encourage healthy eating by “nudging” consumers towards genetically optimal buying behaviour.

By exploring non-invasive behavioural changes and the potential to change human behaviour - without electrodes - Professor Toumazou is making a significant contribution to the UK's leadership in the field of disease prevention and technology-based solutions to improve consumer health.   You can download the full report here.


Our News

10th September 2019
DnaNudge founder co-chairs Royal Society report on neural interfaces

24th January 2017
Consumer genetics pioneer DnaNudge – Finalist of World Technology Award for Health & Medicine – Becomes Member of WTN

2nd December 2016
Regius Professor Chris Toumazou honoured with Lifetime Achievement accolade at Elektra European Electronics Industry Awards

Close